Assessing Innovative Wireless and Wearable Sensors for Continuous Blood Pressure Measurement in Obese Pregnant Women
1 other identifier
interventional
20
0 countries
N/A
Brief Summary
This study is a prospective study targeting at least 20 obese and super-obese patients admitted to Labor \& Delivery (L\&D) for delivery at UNC Medical Center. Patients with clinical indicated radial A-lines either planned or already in-situ will be offered participation. The study will evaluate the accuracy of noninvasive blood pressure measurements with the ANNE One system to blood pressure readings with the radial A-line.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2023
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 15, 2023
CompletedFirst Posted
Study publicly available on registry
March 30, 2023
CompletedStudy Start
First participant enrolled
May 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedMarch 30, 2023
March 1, 2023
8 months
March 15, 2023
March 15, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Mean absolute error (MAE) and standard deviation of blood pressure measurements with ANNE One compared to arterial line
Mean absolute error and standard deviation between the non-invasive blood pressure measurement provided by the device under test and the invasive blood pressure measurement from the arterial line.
8 hours
Study Arms (1)
Comparison of ANNE One system blood pressure measurements to arterial line
EXPERIMENTALInterventions
Chest sensor for single lead ECG and finger sensor for pulse oximetry.
Eligibility Criteria
You may qualify if:
- Age \>= 18 years old
- Ability and willingness to provide written informed consent
- Admitted for delivery at UNC Medical Center
- BMI of \>= 40 kg/m2
- Clinically indicated radial A-lines either planned or already in-situ prior to delivery
You may not qualify if:
- Skin sensitivity or allergy that precludes placement of ANNE One
- Any condition (social or medical) which, in the opinion of the study staff would make any study participation unsafe or complicate data interpretation
- Expected delivery within \<= 1 hour of arrival to L\&D
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sibel Health Inc.lead
- University of North Carolinacollaborator
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 15, 2023
First Posted
March 30, 2023
Study Start
May 1, 2023
Primary Completion
December 31, 2023
Study Completion
December 31, 2023
Last Updated
March 30, 2023
Record last verified: 2023-03